According to
Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:
1. Omnicell (NASDAQ:OMCL)
Omnicell (NASDAQ:OMCL) is the #1 top health information service stock out of 53 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.
Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 50, which is 19 points higher than the health information service industry average of 31.
OMCL passed 16 out of 33 due diligence checks and has strong fundamentals. Omnicell has seen its stock return 22.22% over the past year, overperforming other health information service stocks by 61 percentage points.
Omnicell has an average 1 year
price target of $58.50, an upside of 53.22% from Omnicell's current stock price of $38.18.
Omnicell stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Omnicell, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Progyny (NASDAQ:PGNY)
Progyny (NASDAQ:PGNY) is the #2 top health information service stock out of 53 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year.
Learn more.
The Component Grade breakdown for Progyny (NASDAQ:PGNY) is: Value: C, Growth: C, Momentum: C, Sentiment: B, Safety: B, Financials: A, and AI: C.
Progyny (NASDAQ:PGNY) has a Due Diligence Score of 58, which is 27 points higher than the health information service industry average of 31.
PGNY passed 19 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock return 15.43% over the past year, overperforming other health information service stocks by 54 percentage points.
Progyny has an average 1 year
price target of $29.57, an upside of 14.22% from Progyny's current stock price of $25.89.
Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Progyny, 85.71% have issued a Strong Buy rating, 14.29% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Hinge Health (NYSE:HNGE)
Hinge Health (NYSE:HNGE) is the #3 top health information service stock out of 53 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year.
Learn more.
The Component Grade breakdown for Hinge Health (NYSE:HNGE) is: Value: C, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: A.
Hinge Health (NYSE:HNGE) has a Due Diligence Score of 32, which is 1 points higher than the health information service industry average of 31.
HNGE passed 11 out of 33 due diligence checks and has average fundamentals. Hinge Health has seen its stock return 69.61% over the past year, overperforming other health information service stocks by 108 percentage points.
Hinge Health has an average 1 year
price target of $65.09, an upside of 4.88% from Hinge Health's current stock price of $62.06.
Hinge Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Hinge Health, 63.64% have issued a Strong Buy rating, 36.36% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
